Cimetidine Fe Silibinin is the major active

Silibinin is the major active constituent of silymarin

TAK-285 was found to be well tolerate in Phase I trials

MK 0893 is proved to be a competitive

In an in vitro kinase assay

Smiles: CC(=O)C1C(=O)N(C2CCCC2)C2=NC(NC3=CC=C(C=N3)N3CCNCC3)=NC=C2C=1C

Cimetidine Fe Silibinin is the major activeCimetidine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is largely used in the treatment of heartburn and peptic ulcers. Enhancing anti tumor cell mediated responses, cimetidine blocks histamine's ability to stimulate suppressor T lymphocyte activity and to inhibit natural killer cell activity and interleukin 2 production. Cimetidine also may inhibit tumor growth by suppressing histamine's growth factor activity and